Clay Northam Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$318K Hold
265
0.16% 79
2026
Q1
$244K Buy
265
+7
+3% +$7.1K 0.14% 90
2025
Q4
$277K Buy
+258
New +$247K 0.15% 77
2025
Q3
Sell
-258
Closed -$201K 101
2025
Q2
$201K Buy
258
+15
+6% +$11.7K 0.13% 87
2025
Q1
$201K Buy
+243
New +$202K 0.14% 85
2024
Q4
Sell
-226
Closed -$200K 96
2024
Q3
$200K Hold
226
0.14% 90
2024
Q2
$205K Buy
+226
New +$181K 0.16% 83

Other funds holding LLY

Clay Northam Wealth Management's LLY Position: Q2 2026 in Review

Clay Northam Wealth Management held its Eli Lilly (LLY) position steady in Q2 2026 at 265 shares worth $318K. The position accounts for 0.16% of the portfolio, ranked #79.

Clay Northam Wealth Management first reported a position in LLY in Q2 2024 and has held it in 7 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Clay Northam Wealth Management held 265 shares of Eli Lilly worth $318K as of Q2 2026.
  • Clay Northam Wealth Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.16% of Clay Northam Wealth Management's portfolio in Q2 2026, its #79 holding.
  • Clay Northam Wealth Management first reported a position in Eli Lilly in Q2 2024 and has held it in 7 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Clay Northam Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.